Glen Santangelo
Stock Analyst at Jefferies
(1.83)
# 3,014
Out of 4,712 analysts
71
Total ratings
46.51%
Success rate
-2.49%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $19.81 | -9.14% | 2 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $14.71 | +63.15% | 4 | Sep 19, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $8 → $10 | $9.53 | +4.93% | 6 | Sep 17, 2024 | |
| VTRS Viatris | Reinstates: Buy | $15 | $12.56 | +19.43% | 3 | Jul 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $28.49 | -19.27% | 4 | Jun 27, 2024 | |
| TEVA Teva Pharmaceutical | Maintains: Buy | $19 → $23 | $22.62 | +1.68% | 4 | Jun 27, 2024 | |
| COLL Collegium Pharmaceutical | Upgrades: Buy | $41 → $44 | $29.49 | +49.20% | 3 | Jun 7, 2024 | |
| ELAN Elanco Animal Health | Initiates: Buy | $17 | $12.05 | +41.08% | 1 | Dec 19, 2023 | |
| ZTS Zoetis | Assumes: Buy | $230 | $165.52 | +38.96% | 1 | Dec 19, 2023 | |
| VRCA Verrica Pharmaceuticals | Reiterates: Buy | $10 | $0.65 | +1,441.54% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $38.17 | +83.39% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $14 | $3.57 | +292.16% | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5.5 | $1.22 | +350.82% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $3.50 | +14.29% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $8.10 | +97.53% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $3.42 | +309.36% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5 | $0.42 | +1,096.74% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $58.42 | -21.26% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $97.41 | -17.87% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $7.09 | +294.92% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $25.76 | +171.74% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $7.70 | +1,458.44% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $3.22 | -37.89% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.52 | +939.82% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $4.25 | +747.06% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $44.92 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $578.43 | -70.78% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $30.89 | - | 2 | Jan 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $119.20 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $70.97 | +15.54% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $19.16 | +322.76% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $215.50 | +16.01% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $9.68 | +705.79% | 1 | Dec 4, 2017 |
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $19.81
Upside: -9.14%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $14.71
Upside: +63.15%
Teladoc Health
Sep 17, 2024
Maintains: Hold
Price Target: $8 → $10
Current: $9.53
Upside: +4.93%
Viatris
Jul 19, 2024
Reinstates: Buy
Price Target: $15
Current: $12.56
Upside: +19.43%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $28.49
Upside: -19.27%
Teva Pharmaceutical
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $22.62
Upside: +1.68%
Collegium Pharmaceutical
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $29.49
Upside: +49.20%
Elanco Animal Health
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $12.05
Upside: +41.08%
Zoetis
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $165.52
Upside: +38.96%
Verrica Pharmaceuticals
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.65
Upside: +1,441.54%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $38.17
Upside: +83.39%
Feb 9, 2023
Downgrades: Hold
Price Target: $14
Current: $3.57
Upside: +292.16%
Oct 21, 2022
Initiates: Hold
Price Target: $5.5
Current: $1.22
Upside: +350.82%
Oct 21, 2022
Assumes: Buy
Price Target: $4
Current: $3.50
Upside: +14.29%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $8.10
Upside: +97.53%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $3.42
Upside: +309.36%
Oct 21, 2022
Assumes: Buy
Price Target: $5
Current: $0.42
Upside: +1,096.74%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $58.42
Upside: -21.26%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $97.41
Upside: -17.87%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $7.09
Upside: +294.92%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $25.76
Upside: +171.74%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $7.70
Upside: +1,458.44%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $3.22
Upside: -37.89%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.52
Upside: +939.82%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $4.25
Upside: +747.06%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $44.92
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $578.43
Upside: -70.78%
Jan 7, 2020
Upgrades: Buy
Price Target: n/a
Current: $30.89
Upside: -
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $119.20
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $70.97
Upside: +15.54%
Dec 8, 2017
Initiates: Buy
Price Target: $81
Current: $19.16
Upside: +322.76%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $215.50
Upside: +16.01%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $9.68
Upside: +705.79%